Statistics for Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab
Total visits
| views | |
|---|---|
| Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab | 133 |
Total visits per month
| views | |
|---|---|
| November 2024 | 3 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Soluble human Suppression of Tumorigenicity 2.pdf(legacy) | 100 |
| Soluble human Suppression of Tumorigenicity 2.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 56 |
| China | 29 |
| Germany | 10 |
| Sweden | 8 |
| United Kingdom | 5 |
| Portugal | 5 |
| Canada | 4 |
| Singapore | 3 |
| Australia | 2 |
| India | 1 |
| South Korea | 1 |
| Netherlands | 1 |
| Russia | 1 |
| Slovakia | 1 |